Skip to main content
Fig. 2 | Arthritis Research & Therapy

Fig. 2

From: Association of biochemical markers with bone marrow lesion changes on imaging—data from the Foundation for the National Institutes of Health Osteoarthritis Biomarkers Consortium

Fig. 2

Receiver operating characteristic curves of biochemical markers for predicting the presence and absence of bone marrow lesions at baseline. A unadjusted and B adjusted for covariates. Serum type I, type II, and type III collagen degradation mediated by matrix metalloproteinase (MMP) cleavage (C1M, C2M, C3M), serum propeptide of type IIb collagen (hsPRO-C2), and serum metabolite of C-reactive protein (CRPM)

Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us